- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-1/A IPO registration
- 1.1 Form of Underwriting Agreement
- 3.1 Form of Certificate of Amendment to the Certificate of Incorporation
- 3.1 Form of Amended and Restated Certificate of Incorporation
- 4.1 Form of Amendment to Series a Preferred Stock Warrant
- 10.3 Amendment to Employment Agreement Dated May 18, 2020 with Panna Sharma
- 10.4 Employment Agreement Dated May 18, 2020 with David Margrave
- 10.15 Form of Lock-up Agreement
- 10.16 Employment Agreement Dated May 18, 2020 with Kishor G Bhatia
- 23.1 Consent of Eisneramper LLP, Independent Registered Public Accounting Firm
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this amendment No. 2 to the Registration Statement of Lantern Pharma Inc. on Form S-1 (No. 333-237714) to be filed on or about May 18, 2020 of our report dated April 16, 2020, except for Note 11, which is May 11, 2020, on our audit of the consolidated financial statements as of December 31, 2019 and 2018 and for each of the years then ended. Our report includes an explanatory paragraph about the existence of substantial doubt concerning the Company’s ability to continue as a going concern. We also consent to the reference to our firm under the caption “Experts” in this Registration Statement.
/s/EisnerAmper LLP
EISNERAMPER LLP
Iselin, New Jersey
May 18, 2020